Bladder Tumor Associated Antigen
8100500
Ordering Recommendation
May be useful in diagnosis of urothelial carcinoma and monitoring of tumor recurrence.
Submit With Order
Mnemonic
BT REPORT
Methodology
Qualitative Immunoassay
Performed
Mon-Fri
Reported
1-5 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Urine.  
Specimen Preparation
Transport 2 mL urine.  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Bladder washings, plasma, serum, or whole blood.  
Remarks
 
Stability
Ambient: 48 hours; Refrigerated: 1 week; Frozen: 6 months  
Reference Interval
Positive: Bladder tumor associated antigen detected.
Negative: Bladder tumor associated antigen not detected.
Interpretive Data
Results of the BTA stat® test should not be interpreted as absolute evidence for the presence or absence of bladder cancer. Any disease that would cause endogenous human complement factor H (hCFH) to leak into the bladder can cause a positive test result; including renal stones, nephritis, renal cancer, urinary tract infections, cystitis, or recent trauma to the bladder or urinary tract.
Note
CPT Code(s)
86294
Components
Component Test Code*Component Chart Name
2006604Clinical History
8100523Bladder Tumor Antigen Specimen Source
8100530Interpretation
8100535Comments
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Cross References
  • Bladder Cancer